DAY 2 - Friday, 10 April 2026

Topic

Activity

Time

Learning Objectives

Category

Speaker

KEYNOTE TALKS (8am to 11am) 180 min

Controversies in Neurovascular Practice

MODERATORS:

1

ACT-GLOBAL and the Future of Stroke Trials: Are We Entering the Post-RCT Era?/Evolving Evidence in Endovascular Stroke Intervention: Bridging Randomized Trials, Real-World Data, and Clinical Practice

Presentation

8am (30 min)

Summarize key findings from ACT-GLOBAL and other contemporary stroke trials.
Compare evidence derived from RCTs versus real-world and registry-based data.
Evaluate how evolving evidence influences endovascular stroke practice.
Apply integrated trial and real-world data to clinical decision-making in stroke intervention.

1

Hosam Al Jehani (Canada)

4

Current Indications and Future Role for EC-IC Bypass

Presentation

8.30am (30 min)

Describe current clinical indications for EC–IC bypass surgery.
Identify patient and disease characteristics that may benefit from revascularization.
Evaluate contemporary evidence and limitations influencing EC–IC bypass outcomes.
Discuss the potential future role of EC–IC bypass in selected cerebrovascular conditions.

1

Jash Patel (UK)

2

Role of Surgery in Multi-modal Treatment of Cererbal AVM

Presentation

9am (30 min)

Describe the role of microsurgical resection within multimodal treatment strategies for cerebral AVMs.
Identify AVM characteristics that favor surgical intervention versus endovascular or radiosurgical approaches.
Integrate surgery with embolization and radiosurgery to optimize outcomes.
Apply multidisciplinary decision-making to individualized cAVM management.

1

Jawad Yousaf (Qatar)

3

Endovascular Therapy for AVM: New Strategies and Techniques

Presentation

9.30am (30 min)

Describe contemporary endovascular strategies and techniques for AVM treatment.
Identify advances in embolic materials, devices, and procedural approaches.
Evaluate outcomes, risks, and limitations of modern endovascular AVM therapy.
Integrate endovascular techniques into multimodal, patient-specific AVM management plans.

1

TBA

5

Advances in Radiosurgery for Cerebral AVMs: Precision, Challenges, and Treatment Outcomes

Presentation

10am (30 min)

Describe recent advances in radiosurgical techniques for cerebral AVMs.
Identify factors influencing precision, targeting, and dose planning.
Evaluate treatment outcomes, latency risks, and complications.
Integrate radiosurgery into multimodal AVM management strategies.

1

 Raphael Bodensohn (Germany)

Panel Discussion

10.30am (30 min)

LUNCH BREAK - 11am to 1pm

PARALLEL SESSION 1 (1pm to 3pm) 120 min

Horizons in Microsurgical & Endovascular Surgery

MODERATORS:

1

Role of Surgical Clipping of Intracranial Aneurysms in the Endovascular Era

Presentation

1pm (20 min)

Describe the evolving role of surgical clipping in the contemporary endovascular era.
Identify aneurysm characteristics best suited for microsurgical clipping.
Compare outcomes, risks, and durability of clipping versus endovascular techniques.
Apply patient- and aneurysm-specific factors to guide optimal treatment selection.

1

Jash Patel (UK)

2

Intra-aneurysmal Flow Disruptors: A new era of in aneurysmal treatment

Presentation

1.20pm (20 min)

Describe the principles and mechanisms of intra-aneurysmal flow disruptor devices.
Identify aneurysm types and patient profiles suitable for flow disruption therapy.
Evaluate current evidence on safety, efficacy, and clinical outcomes.
Integrate flow disruptors into contemporary aneurysm treatment algorithms.

1

Saruhan Çekirge (Turkey)

3

Endovascular Treatment of Intracranial Aneurysms - learning outcomes from the Meta Study

Presentation

1.40pm (20 min)

Summarize key findings from meta-analyses on endovascular treatment of intracranial aneurysms
Compare efficacy and safety outcomes across endovascular techniques.
Interpret pooled evidence to inform patient and aneurysm selection.
Apply meta-study insights to optimize contemporary endovascular practice.

1

Cathal Hannan (UK)

4

Fusiform Intracranial Aneurysms: Evolving Insights into Natural History and Treatment Outcomes

Presentation

2pm (20 min)

Describe the natural history and progression patterns of fusiform intracranial aneurysms.
Identify clinical and imaging factors influencing rupture risk and prognosis.
Compare outcomes of contemporary surgical and endovascular treatment options.
Apply evidence-based insights to guide individualized management decisions.

1

Cathal Hannan (UK)

5

Get It Right the First Time? Multi-Stage Endovascular Strategies in Complex Intracranial Aneurysm Management

Presentation

2.20pm (20 min)

Differentiate aneurysm scenarios suitable for single-stage definitive treatment versus staged approaches.
Evaluate clinical, anatomical, and technical factors influencing initial treatment strategy.
Compare outcomes, risks, and durability of upfront versus multi-stage aneurysm management.
Apply strategic decision-making to optimize safety and long-term outcomes in complex aneurysm care.

1

Hosam Al Jehani (Canada)

Panel Discussion

2.40pm (20 min)

Precision in Stroke Neurology

MODERATORS:

1

The Changing Role of Reversal Agents in Acute Stroke Patients: Is it time for a paradigm shift?

Presentation

1pm (20 min)

Summarize current and emerging reversal agents used in acute stroke care.
Identify indications and patient selection for anticoagulant and antiplatelet reversal.
Evaluate evidence, risks, and workflow implications influencing reversal decisions.
Apply a paradigm-based approach to reversal strategies in contemporary stroke management.

1

Senta Frol (Slovenia)

2

Targeting Secondary Injury After ICH: Beyond Clot Evacuation

Presentation

1:20 PM (20 min)

1

Victor C. Urrutia (USA)

3

Imaging-Guided Thrombectomy: Who to Treat, When to Treat, and When Not to Treat

Presentation

1.40pm (20 min)

Interpret advanced imaging criteria used to select patients for thrombectomy.
Determine optimal timing for intervention across early and late windows.
Identify scenarios where thrombectomy may be futile or harmful.
Apply imaging-guided decision-making to optimize outcomes in acute stroke care.

1

Hosam Al Jehani (KSA)

4

Tenecteplase (TNK) for Acute Thrombolysis: Should We Make the Switch

Presentation

2pm (20 min)

Summarize current evidence comparing tenecteplase and alteplase for acute ischemic stroke thrombolysis.
Identify patient selection criteria and dosing considerations for TNK use.
Evaluate safety, efficacy, and workflow implications of switching to TNK.
Apply evidence-based guidance to thrombolysis decision-making in clinical practice.

1

Senta Frol (Slovenia)

5

Migraine, PFO, and Cryptogenic Stroke: Connecting the Dots in the Precision Era

Presentation

2.20pm (20 min)

Describe the proposed pathophysiological links between migraine, PFO, and cryptogenic stroke.
Identify patients in whom PFO evaluation is clinically relevant.
Evaluate current evidence for PFO closure in migraine and cryptogenic stroke.
Apply precision-based decision-making to individualized patient management.

1

Amal Al Hashmi (Oman)

Panel Discussion

2.40pm (20 min)

BREAK 3pm to 3.15pm

PARALLEL SESSION 2 (3.15pm to 5pm) 105 min

Young Neurosurgeon Sessions

MODERATORS:

1

White Matter Fiber Dissection

 Presentation

3.15pm (20 min)

Describe the principles and methodology of white matter fiber dissection.
Identify major white matter tracts relevant to neurosurgical anatomy.
Correlate fiber dissection findings with imaging and surgical approaches.
Apply white matter anatomy knowledge to improve surgical planning and safety.

1

Ismail Ughratdar (UK)

2

Learning Curve in Neurosurgery

 Presentation

3.35pm (20 min)

Describe the concept and phases of the learning curve in neurosurgical practice.
Identify factors influencing skill acquisition, performance, and patient safety.
Evaluate the role of simulation, mentorship, and technology in shortening learning curves.
Apply strategies to optimize training outcomes while minimizing procedural risk.

1

Jawad Yousaf (Qatar)

3

Nuances in Microneurosurgery: tips and Tricks

 Presentation

3.55pm (20 min)

Identify key technical nuances that enhance precision in microneurosurgery.
Apply practical tips to optimize exposure, tissue handling, and instrument control.
Recognize common pitfalls and strategies to avoid intraoperative complications.
Refine microsurgical technique to improve safety and surgical outcomes.

1

Amrou Elhajali (Qatar)

5

Mentorship and Career Counselling: Session with International and regional faculty

 Presentation

4.15pm (25 min)

Identify key elements of effective mentorship in neurosurgical training and practice
Explore diverse career pathways through insights from international and regional faculty.
Apply strategies for career planning, academic development, and leadership growth.
Engage in meaningful mentor–mentee relationships to support long-term professional success.

1

Faculty Panel

Panel Discussion

4.45pm (20 min)

Headaches and Pain Disorders

MODERATORS:

1

The High-Pressure Frontier: Network Failure and CSF Dysregulation in Idiopathic Intracranial Hypertension

Presentation

3.15pm (25 min)

Describe emerging concepts of network failure and CSF dysregulation in idiopathic intracranial hypertension
Identify clinical, radiological, and physiological markers of raised intracranial pressure.
Evaluate current and evolving diagnostic and therapeutic strategies.
Apply mechanistic insights to individualized management of IIH.

1

Teshamae Monteith (USA)

Falling Through the Floor: Spontaneous Intracranial Hypotension and Collapse of CSF Homeostasis

Presentation

3.35pm (20 min)

Describe the pathophysiology of spontaneous intracranial hypotension and CSF homeostasis failure.
Identify key clinical and imaging features associated with SIH.
Evaluate current diagnostic pathways and treatment options, including targeted therapies.
Apply a structured approach to diagnosis and management to improve patient outcomes.

1

Teshamae Monteith (USA)

2

Beyond CGRP, the next frontier in Migraine prevention

Presentation

3.55pm (20 min)

Describe emerging preventive targets beyond CGRP in migraine pathophysiology.
Identify novel pharmacologic and device-based therapies in development or early use.
Evaluate current evidence supporting next-generation migraine prevention strategies.
Apply individualized preventive approaches to optimize efficacy and tolerability.

1

Jasem Al Hashel (Kuwait)

4

The New Frontier of Trigeminal Autonomic Cephalalgias (TACs): From Precision Phenotyping to Targeted Therapies.

Presentation

4.15pm (20 min)

Differentiate trigeminal autonomic cephalalgias using precision clinical phenotyping.
Identify key pathophysiological mechanisms underlying TACs.
Summarize emerging targeted and neuromodulatory therapies for TACs.
Apply phenotype-driven strategies to optimize diagnosis and individualized treatment.

1

Jasem Al Hashel (Kuwait)

Panel Discussion

4.45pm (20 min)

END OF DAY 2 SESSIONS - 5pm​​​​